AIM CIK: 946644

AIM ImmunoTech Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.0
FY22:
−16.1
FY23:
−21.3
FY24:
−14.9
FY25:
−11.0
Change from FY21 to FY25
millions USD
FY21:
−0.63
FY22:
11.0
FY23:
−0.83
FY24:
4.71
FY25:
1.85
Change from FY21 to FY25
millions USD
FY21:
8.19
FY22:
0.08
FY23:
0.49
FY24:
6.44
FY25:
10.4
millions USD
FY21:
−6.41
FY22:
−5.04
FY23:
−21.6
FY24:
−3.74
FY25:
1.28
(positive)
Change from FY21 to FY24
millions USD
FY21:
−14.0
FY22:
−16.2
FY23:
–
FY24:
−14.9
FY25:
–

All amounts in millions USD Data source:SEC EDGAR